ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer-Reference-Cited by-同舟云学术

ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer

Published:2017-06-01 Issue:12 Volume:109 Page:
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Pietrantonio Filippo¹,Di Nicolantonio Federica²³,Schrock Alexa B⁴,Lee Jeeyun⁵,Tejpar Sabine⁶,Sartore-Bianchi Andrea⁷,Hechtman Jaclyn F⁸,Christiansen Jason⁹,Novara Luca²,Tebbutt Niall¹⁰,Fucà Giovanni¹,Antoniotti Carlotta¹¹¹²,Kim Seung Tae⁵,Murphy Danielle⁹,Berenato Rosa¹,Morano Federica¹,Sun James⁴,Min Bosun⁹,Stephens Philip J⁴,Chen Marissa⁹,Lazzari Luca²³,Miller Vincent A⁴,Shoemaker Robert⁹,Amatu Alessio⁷,Milione Massimo¹³,Ross Jeffrey S¹⁴,Siena Salvatore⁷¹⁵,Bardelli Alberto²³,Ali Siraj M⁴,Falcone Alfredo¹¹¹²,de Braud Filippo¹¹⁵,Cremolini Chiara¹¹¹²

Affiliation:

1. Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

2. Department of Oncology, University of Torino, Candiolo (TO), Italy

3. Candiolo Cancer Institute-FPO, IRCCS, Candiolo (TO), Italy

4. Foundation Medicine, Inc., Cambridge, MA

5. Samsung Medical Center, Sungkyunkwan University School of Medicine, Kangnamgu, Seoul, Korea

6. Molecular Digestive Oncology Unit, University Hospital Gasthuisberg, Leuven, Belgium

7. Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy

8. Memorial Sloan Kettering Cancer Center, New York, NY

9. Ignyta Inc., San Diego, CA

10. Austin Health, Melbourne VIC, Australia

11. Azienda Ospedaliero, Universitaria Pisana, Pisa, Italy

12. University of Pisa, Pisa, Italy

13. Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

14. Department of Pathology, Albany Medical College, Albany, NY

15. Department of Oncology and Hemato-oncology, Università degli Studi di Milano, Milan, Italy

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/109/12/djx089/24150266/djx089.pdf

Reference34 articles.

1. Tyrosine kinase gene rearrangements in epithelial malignancies;Shaw;Nat Rev Cancer.,2013

2. The landscape of kinase fusions in cancer;Stransky;Nat Commun.,2014

3. NTRK gene fusions as novel targets of cancer therapy across multiple tumour types;Amatu;ESMO Open,2016

4. Broad detection of alterations predicted to confer lack of benefit from EGFR antibodies or sensitivity to targeted therapy in advanced colorectal cancer;Rankin;Oncologist,2016

5. ROS1 and ALK fusions in colorectal cancer, with evidence of intratumoral heterogeneity for molecular drivers;Aisner;Mol Cancer Res,2014

Cited by 183 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation and interpretation of Pan-TRK immunohistochemistry: a practical approach and challenges with interpretation;Diagnostic Pathology;2024-01-10

2. Primary mucinous adenocarcinoma of the urethra: A clinicopathological analysis of 35 cases;Histopathology;2023-12-19

3. Le cancer colorectal à l’ère de la médecine de précision;Bulletin de l'Académie Nationale de Médecine;2023-12

4. Pathologic Evaluation of Therapeutic Biomarkers in Colorectal Adenocarcinoma;Surgical Pathology Clinics;2023-12

5. Construction and Evaluation of an M2 Macrophage-Related Prognostic Model for Colon Cancer;Applied Biochemistry and Biotechnology;2023-11-21